Background Ictal-interictal continuum (IIC) continuous EEG (cEEG) patterns including periodic discharges and rhythmic delta activity are associated with poor outcome and in the appropriate clinical context, IIC patterns may represent ''electroclinical'' status epilepticus (SE). To clarify the significance of IIC patterns and their relationship to ''electrographic'' SE, we investigated FDG-PET imaging as a complementary metabolic biomarker of SE among patients with IIC patterns. Methods A single-center prospective clinical database was ascertained for patients undergoing FDG-PET during cEEG. Following MRI-PET co-registration, the maximum standardized uptake value in cortical and subcortical regions was compared to contralateral homologous and cerebellar regions. Consensus cEEG review and clinical rating of etiology and treatment response were performed retrospectively with blinding. Electrographic SE was classified as discrete seizures without interictal recovery or >3-Hz rhythmic IIC patterns. Electroclinical SE was classified as IIC patterns with electrographic and clinical response to anticonvulsants; clonic activity; or persistent post-ictal encephalopathy. Results Eighteen hospitalized subjects underwent FDG-PET during contemporaneous IIC patterns attributed to structural lesions (44 %), neuroinflammatory/neuroinfectious disease (39 %), or epilepsy (11 %). FDG-PET hypermetabolism was common (61 %) and predicted electrographic or electroclinical SE (sensitivity 79 % [95 % CI 53-93 %] and specificity 100 % [95 % CI 51-100 %]; p = 0.01). Excluding electrographic SE, hypermetabolism also predicted electroclinical SE (sensitivity 80 % [95 % CI 44-94 %] and specificity 100 % [95 % CI 51-100 %]; p = 0.01). Conclusions In hospitalized patients with IIC EEG patterns, FDG-PET hypermetabolism is common and is a candidate metabolic biomarker of electrographic SE or electroclinical SE.
Introduction
Continuous electroencephalography (cEEG) commonly identifies periodic and rhythmic patterns on the ictal-interictal continuum (IIC) in patients with neurologic injury [1] . IIC patterns are associated with poor neurologic outcome [2] [3] [4] , even in the absence of electrographic status epilepticus (SE). The significance of these patterns in relation to cerebral dysfunction and neurologic injury remains unclear [5] .
Electrographic SE represents the transition from an indeterminate EEG pattern, that is, an IIC pattern, to a definitively ictal pattern and electrographic SE is associated with significant morbidity and mortality [6, 7] . However, IIC patterns without definite electrographic status epilepticus on scalp EEG are often observed in relation to clonic movements, encephalopathy following status epilepticus [8] or synchronized with depth seizures in the setting of coma [9] . As a result, IIC patterns are often managed as electroclinical SE in the appropriate clinical context, and may respond to anti-epileptic drugs (AEDs).
Measurements of metabolism in patients with IIC patterns may offer information complementary to and distinct from EEG activity. 18 F-Fluorodeoxyglucose positron emission tomography (FDG-PET) represents an opportunity to further characterize the metabolic impact of IIC patterns potentially signifying neuronal injury or metabolic stress that might guide treatment. FDG-PET measures glucose uptake and commonly demonstrates hypermetabolism during seizures and status epilepticus [10] [11] [12] [13] [14] [15] , whileAQ infarcted cerebral tissue manifests reduced glucose uptake. Most cerebral metabolic activity (80-85 %) is related to propagation of action potentials and restoring post-synaptic ion fluxes primarily related to glutamate, making metabolism a fairly direct measure of neuronal activity [16] . There have only been single case reports demonstrating FDG-PET metabolic changes corresponding to IIC patterns [10, [17] [18] [19] . We therefore investigated FDG-PET cerebral metabolism as a candidate biomarker for electrographic SE or electroclinical SE among patients with IIC patterns.
Methods Subjects
After local institutional review board approval, a singlecenter prospective clinical EEG database was queried for inpatients between 2005 and 2014 undergoing cEEG and cerebral FDG-PET. Inclusion criteria included FDG-PET imaging available for analysis, raw structural imaging available for anatomic co-registration, cEEG performed immediately prior to and immediately after FDG-PET imaging, and presence of IIC patterns: periodic discharges (PD), rhythmic delta activity (RDA), spike-wave activity (SW), or electrographic SE on cEEG at the time of PET injection. We excluded patients undergoing FDG-PET for elective characterization of chronic epilepsy. 
FDG-PET Acquisition
PET imaging was performed under standard protocol, 45 min after injection of 5.0 mCi of FDG, and acquired on an ECAT HR+ scanner (Siemens/CTI, Knoxville, TN). A 15.5-cm field of view was acquired with sixty-three planes simultaneously in 3D mode. For attenuation correction a transmission scan with a 68 Ge source was used. Reconstruction was performed using a maximum likelihood algorithm. Images had approximately 4.6-mm resolution at full width at half maximum.
PET Interpretation
An investigator blinded to the cEEG results used a semiquantitative method to define the degree and extent of FDG-PET uptake. This analysis was performed blinded to the initial ''clinical'' interpretation of the PET. PET was co-registered to T1 MRI. A 10 % color gradation [blue (hypo), green, yellow, red (hyper)] with cerebellum set to yellow, was used to highlight areas of abnormality. The maximum standardized uptake value (SUV max ) was measured regionally in the mesial temporal, basal ganglia, and thalamic regions, and neo-cortex (rated over frontal, temporal, parietal, and occipital regions). The SUV max was calculated as the voxel of highest SUV for a specified region. The SUV has been described as a ratio of radioactivity per a voxel expressed as a concentration (megaBecquerel per kilogram) divided by injected dose of radiation per kilogram of body mass [20] . Lack of arterial blood sampling prevented direct quantification of glucose metabolism. Because acute neurologic injury limited the utility of healthy subjects as a reference standard, we prespecified that a 20 % relative difference in SUV max (rSUV max ) compared with an internal control to ascertain differences in FDG uptake [21] . For focal abnormalities a contralateral homologous region was used to calculate the reference rSUV max . Regions with altered metabolism were also compared to the total cerebellar SUV max . If bilateral changes were ascertained on visual inspection, the contralateral reference was not available and we accordingly employed a threshold of 50 % increase of SUV max relative to cerebellum, (a 99 % confidence interval assuming a normal distribution and with a 0.2 standard deviation) [22, 23] . Hypermetabolism and hypometabolism were classified as focal (present in a single region), regional (extending to subcortical or adjacent regions), or 3 diffuse (bilateral).
EEG Review
ACNS terminology-certified [1] clinical neurophysiologists blinded to clinical and PET data rated cEEG for discrete seizures, periodic discharges including modifiers frequency, location, amplitude, superimposed fast frequencies, rhythmic activity, sharp activity, and triphasic morphology. Discrepancies were resolved by consensus.
Determination of Status Epilepticus
No gold standard external to EEG exists to determine if a patient is in SE. We operationally differentiated [24, 25] . Clinical records were assessed by a neurologist blinded to cEEG and PET results for disease etiology and response to AED treatment.
Statistical Analysis
Categorical variables were analyzed for significance using Fisher-exact test. 95 % confidence intervals for proportions were generated using Wilson test with continuity correction [26] . Statistical analyses were performed using MATLAB 2013B (Natick, MA) and R 3.1.3 (The R Foundation for Statistical Computing; http:// www.R-project.org.
Results

Patient Characteristics
Between 2005 and 2014, 18 inpatients met the selection criteria (mean age 56.6; range 14-83). All patients were on AEDs at the time of FDG-PET scanning Table 1 details patient, cEEG, and imaging characteristics, including determination of electrographic SE, electroclinical SE, or IIC patterns without SE. FDG-PET was hypermetabolic in 11 (61 %), hypometabolic in 5 (28 %) and normal in 2 (11 %) patients. Final diagnoses included structural lesions (n = 8; 44 %: of which 6 are ischemic or hemorrhagic strokes, 1 developmental venous anomaly, 1 mechanical injury), neuroinflammatory/neuroinfectious illness (n = 7; 39 %), decompensated epilepsy (n = 2), and CreutzfeldtJakob disease (CJD) (n = 1).
Relation of cEEG Patterns to PET Findings
Among IIC subjects, FDG-PET predicted SE (electrographic or electroclinical,) with 79 % sensitivity (95 % CI 53-93 %) and 100 % specificity (95 % CI 51-100 %); Fisher-exact p = 0.01. For the cohort of subjects without electrographic SE, FDG-PET predicted electroclinical SE with 80 % sensitivity (95 % CI 44-94 %) and 100 % specificity (95 % CI 51-100 %); Fisher-exact p = 0.01. cEEG FDG-PET metabolism was assessed for its dependence on pre-specified candidate variables (Table 2) . Certain cEEG features suggested high specificity for hypermetabolism (>1-Hz or high-amplitude PDs) or high sensitivity (PDs versus RDA) with insufficient statistical power to achieve significance. 
Patterns of Metabolism
Three patterns of hypermetabolism were assessed: focal, regional, and diffuse. Figure 1 shows representative PETs of six subjects, two from each of hypermetabolism with the associated MR and EEG. Two subjects had diffuse hypermetabolism defined as regions of hypermetabolism in both hemispheres. Both presented with NORSE, one with LPDs and the other with 4-Hz GRDA. Five subjects had regional hypermetabolism, two with GPDs the others with LPDs. Subjects with regional hypermetabolism had preexisting focal epilepsy (2), a structural lesion (2), or vasculitis (1). Four subjects had focal hypermetabolism all related to underlying structural lesion. Three had LPDs and the other had GPDs.
Five subjects had hypometabolism. In two patients, hypometabolism was diffuse (CJD, NORSE). The other three had regional or focal hypometabolism, two related to structural lesions and one with encephalitis.
Discussion
In this study, FDG-PET cerebral hypermetabolism similar to that described in cases of SE [5, 13, 18] was significantly more common among patients with IIC patterns fulfilling Fig. 2 The ictal-interictal-injury-metabolism continuum. This diagram is a graphic conceptualization adapted from Chong and Hirsh [24] using the current ACNS terminology and with the addition of PET metabolism ranging from hypo/normo metabolic in blue to hypermetabolic in red. This conceptualization is meant only to reflect scalp EEG patterns. X-axis represents the spectrum of interictal to ictal, i.e., the spectrum of cerebral dysfunction, which is potentially reversible with anti-seizure treatment. Y-axis is secondary neuronal damage attributable to the EEG pattern. SB suppression burst, RDA rhythmic delta activity, LPD lateralized periodic discharges, SW spike wave, GPD generalized periodic discharges, SIRPIDs stimulusinduced rhythmic, periodic, or ictal discharges, NCS non-convulsive seizures, GCSE generalized convulsive status epilepticus, NCSE nonconvulsive electrographic status epilepticus, EPC epilepsia partialis continua, HYPO hypometabolism, HYPER hypermetabolism (Color figure online) Neurocrit Care (2016) 24:324-331 329 published criteria for electrographic SE or electroclinical SE than among patients with IIC patterns alone. Although this cohort is the largest described with concomitant cEEG IIC patterns and concurrent FDG-PET, sample size (n = 18) limited conclusions about specific cEEG features. Additionally, FDG-PET was performed only in complicated cases with high clinical suspicion for SE this represents a referral bias. FDG-PET is not routinely performed in patients with critical neurologic illness for other reasons limiting the ability to generate a relevant set of control subjects. A prospective study of PET neuroimaging may more systematically identify IIC features (e.g., frequency, amplitude) most predictive of hypermetabolism. Additionally, it was difficult to gage the clinical response to AED therapy; clinical response was reviewed retrospectively and FDG-PET findings may have confounded the indication for further anti-seizure medications.
Potential limitations of FDG-PET imaging include spatial averaging from 5-mm resolution limits [20, 27] and temporal averaging during the 45-min uptake period. Examples in our cohort of these limitations may have included focal EPC dominated by surrounding hypometabolism (subject 16) and discrete seizures with intervening GPDs (subject 6). Technical advances with PET-MR and quantitative PET with arterial input function estimations have the potential to reduce the concerns with spatial and time averaging. A potential source of false positives is a hypermetabolic process independent of ictal activity such as encephalitis. Notably, we did not find FDG-PET hypermetabolism in any our cohort among seven subjects with neuroinflammatory/neuroinfectious disease; all were correctly classified except one false negative.
Conclusion
SE and the IIC represent a spectrum of neurophysiologic dysfunction. Some IIC patterns are associated with AEDresponsive reversible cerebral dysfunction due to deepseated or undetected ictal zones or ''burned out'' SE with persistently altered metabolism. Here, we demonstrate that the metabolic effect of IIC in patients with suspected SE without definite electrographic features is similar to the metabolic features of electrographic SE and is not routinely explained by neuroinflammatory or neuroinfectious disease alone. Figure 2 is our adaptation of a diagram describing the IIC initially put forth by Chong and Hirsch [24] . This diagram helps conceptualize the role of metabolism in evaluating SE and the IIC. This study reinforces prior work which raises the possibility of ancillary biomarkers for SE and develops the concept of ''electro-metabolic'' status epilepticus. We put forth FDG-PET as another candidate radiologic biomarker of status epilepticus.
